DK1147115T5 - Tricycliske benzodiazepiner som vasopressinreceptorantagonister - Google Patents
Tricycliske benzodiazepiner som vasopressinreceptorantagonisterInfo
- Publication number
- DK1147115T5 DK1147115T5 DK99966495T DK99966495T DK1147115T5 DK 1147115 T5 DK1147115 T5 DK 1147115T5 DK 99966495 T DK99966495 T DK 99966495T DK 99966495 T DK99966495 T DK 99966495T DK 1147115 T5 DK1147115 T5 DK 1147115T5
- Authority
- DK
- Denmark
- Prior art keywords
- receptor antagonists
- vasopressin receptor
- tricyclic benzodiazepines
- benzodiazepines
- tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11635899P | 1999-01-19 | 1999-01-19 | |
US46865099A | 1999-12-21 | 1999-12-21 | |
PCT/US1999/030423 WO2000043398A2 (fr) | 1999-01-19 | 1999-12-21 | Benzodiazepines tricycliques utilisees en tant qu'antagonistes du recepteur de la vasopressine |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1147115T3 DK1147115T3 (da) | 2004-01-12 |
DK1147115T5 true DK1147115T5 (da) | 2008-12-08 |
Family
ID=26814157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99966495T DK1147115T5 (da) | 1999-01-19 | 1999-12-21 | Tricycliske benzodiazepiner som vasopressinreceptorantagonister |
Country Status (27)
Country | Link |
---|---|
US (2) | US6713475B2 (fr) |
EP (1) | EP1147115B3 (fr) |
KR (1) | KR100771184B1 (fr) |
CN (1) | CN1174986C (fr) |
AR (1) | AR035837A1 (fr) |
AT (1) | ATE249465T1 (fr) |
AU (1) | AU772397B2 (fr) |
BR (1) | BRPI9917086B8 (fr) |
CA (1) | CA2360767C (fr) |
CZ (1) | CZ302647B6 (fr) |
DE (2) | DE69911259D1 (fr) |
DK (1) | DK1147115T5 (fr) |
ES (1) | ES2207333T7 (fr) |
HK (1) | HK1038361B (fr) |
HU (1) | HU229074B1 (fr) |
IL (2) | IL144270A0 (fr) |
ME (1) | ME00129B (fr) |
MY (1) | MY128065A (fr) |
NO (1) | NO327896B1 (fr) |
NZ (1) | NZ512960A (fr) |
PL (1) | PL205704B1 (fr) |
PT (1) | PT1147115E (fr) |
RS (1) | RS50820B (fr) |
TR (1) | TR200102069T2 (fr) |
TW (1) | TWI289564B (fr) |
UA (1) | UA70984C2 (fr) |
WO (1) | WO2000043398A2 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL205704B1 (pl) * | 1999-01-19 | 2010-05-31 | Ortho Mcneil Pharm Inc | Związki tricyklicznej benzodiazepiny, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie |
ATE367815T1 (de) * | 2000-10-04 | 2007-08-15 | Astellas Pharma Inc | Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension |
BR0208823A (pt) | 2001-04-12 | 2004-03-09 | Wyeth Corp | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica |
EP1381608B1 (fr) | 2001-04-12 | 2007-10-10 | Wyeth | Cyclohexylphenyles ayant une activite d'agonistes de la vasopressine |
HUP0401722A3 (en) | 2001-10-29 | 2008-07-28 | Ortho Mcneil Pharm Inc | Benzo[e][1,4]diazepine derivatives condensed with bridged bicycle, their preparation and their use as vasopressin receptor antagonists |
EP1364968A1 (fr) * | 2002-05-23 | 2003-11-26 | Bayer Aktiengesellschaft | Diagnostic et traitement des maladies associées au récepteur 1 d'arginine-vasopressine (AVPR1) |
GB0303852D0 (en) * | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
US7119088B2 (en) | 2003-02-19 | 2006-10-10 | Pfizer Inc. | Triazole compounds useful in therapy |
DK1597260T3 (da) * | 2003-02-19 | 2007-04-02 | Pfizer | Triazol forbindelser, der er anvendelige i behandling |
EP1809296A4 (fr) * | 2004-10-28 | 2009-03-11 | Janssen Pharmaceutica Nv | Nouvelles [1,4]benzodiazepines convenant comme antagonistes du recepteur v-2 de la vasopressine |
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US20090318412A1 (en) * | 2006-07-11 | 2009-12-24 | Takahiro Matsumoto | Tricyclic heterocyclic compound and use thereof |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2011104269A1 (fr) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent pour le positionnement et l'ancrage d'une prothèse valvulaire dans un site d'implantation dans le cœur d'un patient |
AU2009315754B2 (en) * | 2008-11-13 | 2013-08-15 | F. Hoffmann-La Roche Ag | Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes |
EP2358714B1 (fr) * | 2008-11-18 | 2012-08-01 | F. Hoffmann-La Roche AG | Alkylcyclohexyléthers de dihydrotétrazabenzoazulènes |
MX2011005596A (es) * | 2008-11-28 | 2011-06-16 | Hoffmann La Roche | Arilciclohexileteres de dihidro-tetraazabenzoazulenos para uso como antagonistas del receptor de vasopresina via. |
DE102009033392A1 (de) * | 2009-07-16 | 2011-01-20 | Merck Patent Gmbh | Heterocyclische Verbindungen als Autotaxin-Inhibitoren II |
CN102510859A (zh) | 2009-09-24 | 2012-06-20 | 希里-莫韦蒂斯有限公司 | 用作为加压素v2受体拮抗剂的[1,4]-苯二氮 |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
CA2799459A1 (fr) | 2010-05-25 | 2011-12-01 | Jenavalve Technology Inc. | Valvule prothetique et endoprothese mise en place par catheterisme comprenant une valvule prothetique et un stent |
US8828989B2 (en) | 2011-09-26 | 2014-09-09 | Hoffmann-La Roche Inc. | Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists |
CN105491978A (zh) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | 用于假体瓣膜的径向可折叠框架及其制造方法 |
US10508108B2 (en) | 2014-12-05 | 2019-12-17 | Merck Sharp & Dohme Corp. | Tricyclic compounds as inhibitors of mutant IDH enzymes |
WO2016089797A1 (fr) * | 2014-12-05 | 2016-06-09 | Merck Sharp & Dohme Corp. | Composés tricycliques innovants servant d'inhibiteurs d'enzymes idh mutantes |
EP3226690B1 (fr) | 2014-12-05 | 2020-05-20 | Merck Sharp & Dohme Corp. | Nouveaux composés tricycliques comme inhibiteurs d'enzymes idh mutantes |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
EP4183371A1 (fr) | 2016-05-13 | 2023-05-24 | JenaValve Technology, Inc. | Système de pose de prothèse de valvule cardiaque et procédé de pose de prothèse de valvule cardiaque avec gaine d'introduction et système de chargement |
EP3573579B1 (fr) | 2017-01-27 | 2023-12-20 | JenaValve Technology, Inc. | Mimétisme de valve cardiaque |
EP3875078A1 (fr) * | 2020-03-06 | 2021-09-08 | Dompe' Farmaceutici S.P.A. | Des composes pour pour le traitement de covid-19 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3732212A (en) | 1970-04-20 | 1973-05-08 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo(2,1-c)(1,4)benzodiazepine-5,11-diones |
US3763183A (en) * | 1972-07-10 | 1973-10-02 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines |
US3860600A (en) | 1972-07-10 | 1975-01-14 | Sterling Drug Inc | Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines |
US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
US5521173A (en) * | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
CA2285343A1 (fr) * | 1997-03-31 | 1998-10-08 | Wakamoto Pharmaceutical Co., Ltd. | Derives de biphenyle et compositions medicinales |
JP4338305B2 (ja) * | 1997-07-30 | 2009-10-07 | ワイス | 三環系バソプレシンアゴニスト |
PL205704B1 (pl) * | 1999-01-19 | 2010-05-31 | Ortho Mcneil Pharm Inc | Związki tricyklicznej benzodiazepiny, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie |
-
1999
- 1999-12-21 PL PL349778A patent/PL205704B1/pl unknown
- 1999-12-21 DK DK99966495T patent/DK1147115T5/da active
- 1999-12-21 DE DE69911259A patent/DE69911259D1/de not_active Expired - Lifetime
- 1999-12-21 ES ES99966495T patent/ES2207333T7/es active Active
- 1999-12-21 CZ CZ20012598A patent/CZ302647B6/cs not_active IP Right Cessation
- 1999-12-21 PT PT99966495T patent/PT1147115E/pt unknown
- 1999-12-21 TR TR2001/02069T patent/TR200102069T2/xx unknown
- 1999-12-21 IL IL14427099A patent/IL144270A0/xx unknown
- 1999-12-21 HU HU0105034A patent/HU229074B1/hu not_active IP Right Cessation
- 1999-12-21 KR KR1020017009039A patent/KR100771184B1/ko not_active IP Right Cessation
- 1999-12-21 UA UA2001075136A patent/UA70984C2/uk unknown
- 1999-12-21 AU AU22014/00A patent/AU772397B2/en not_active Ceased
- 1999-12-21 CA CA002360767A patent/CA2360767C/fr not_active Expired - Fee Related
- 1999-12-21 NZ NZ512960A patent/NZ512960A/en not_active IP Right Cessation
- 1999-12-21 AT AT99966495T patent/ATE249465T1/de active
- 1999-12-21 BR BRPI9917086A patent/BRPI9917086B8/pt not_active IP Right Cessation
- 1999-12-21 EP EP99966495A patent/EP1147115B3/fr not_active Expired - Lifetime
- 1999-12-21 CN CNB998164887A patent/CN1174986C/zh not_active Expired - Fee Related
- 1999-12-21 WO PCT/US1999/030423 patent/WO2000043398A2/fr active IP Right Grant
- 1999-12-21 DE DE69911259T patent/DE69911259T4/de not_active Expired - Lifetime
- 1999-12-21 ME MEP-2008-178A patent/ME00129B/fr unknown
-
2000
- 2000-01-18 AR ARP000100214A patent/AR035837A1/es active IP Right Grant
- 2000-01-19 MY MYPI20000169A patent/MY128065A/en unknown
- 2000-02-24 TW TW089100772A patent/TWI289564B/zh not_active IP Right Cessation
- 2000-12-21 RS YUP-519/01A patent/RS50820B/sr unknown
-
2001
- 2001-07-11 IL IL144270A patent/IL144270A/en not_active IP Right Cessation
- 2001-07-16 NO NO20013515A patent/NO327896B1/no not_active IP Right Cessation
- 2001-07-24 US US09/911,605 patent/US6713475B2/en not_active Expired - Lifetime
-
2002
- 2002-01-04 HK HK02100064.9A patent/HK1038361B/zh not_active IP Right Cessation
-
2004
- 2004-02-10 US US10/775,675 patent/US7317005B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1147115T5 (da) | Tricycliske benzodiazepiner som vasopressinreceptorantagonister | |
CY2015029I1 (el) | Τρικυκλικοι ανταγωνιστες υποδοχεα θρομβινης | |
DK1224175T3 (da) | Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister | |
BR9710087A (pt) | Antagonistas de vasopressina de benzazepina tricíclicos | |
DE69921351D1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
NO20015779L (no) | Bradykinin-reseptorantagonister | |
DK0811008T3 (da) | Bicycliske benzazepinderivater som vasopressinantagonister | |
PL350234A1 (en) | Heterocyclic benzenesulphonamide compounds as bradykinine antagonists | |
PT1171419E (pt) | Derivados de bifenilo como antagonistas do receptor da neuroquinina-1 | |
GB0026327D0 (en) | Thrombin receptor antagonists | |
DK1131291T3 (da) | 4-aroyl-piperidin-CCR-3-receptorantagonister III | |
SE0003996D0 (sv) | Receptorantagonister |